Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Pharmaceuticals: Major
Sector Health Technology
Employees 12
CEO n/a
Address 400 Oyster Point Boulevard Suite 505, South San Francisco, CA 94080-1958
Phone 1.650.244.4990
Website www.titanpharm.com

Titan Pharmaceuticals, Inc. engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Titan Pharmaceuticals, Inc. -21.20% -69.00%
Omeros Corp. 3.59% 28.88%
Personalis, Inc. -13.56% -11.74%
Oric Pharmaceuticals, Inc. 22.82% 16.51%
908 Devices, Inc. -11.68% n/a

Statement Summary

as of 4:00 ET PM 09/20/2021
Total Assets (MRQ) 11.5 M
Total Liabilities (MRQ) 2.8 M
Shareholders’ Equity (MRQ) 8.7 M
Total Revenue (Annual) 445.0 K
Net Income (Annual) -1.7 M

Earnings And Estimates

as of 4:00 ET PM 09/20/2021

Current Qtr EPS Estimate -0.35
Current FY EPS Estimate -1.34
Long Term EPS Growth Estimate n/a
Next Expected Earnings Date //

TTNP vs S&P 500

as of 09/20/2021
Relative To
S&P 500
TTNP
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 09/20/2021
Fiscal Quarter Estimate Actual Surprise
06/2021 -0.35 -0.35 0.00%
03/2021 -0.85 -0.28 -67.06%
12/2020 -1.33 -1.33 0.00%
09/2020 -1.05 -1.50 +42.86%
06/2020 -1.05 -1.50 +42.86%
12/2019 -1.95 -2.40 +23.08%
09/2019 -6.45 -5.40 -16.28%
06/2019 -8.60 -11.40 +32.56%

Financial Strength

as of 4:00 ET PM 09/20/2021
Pre-Tax Margin -377.53
Net Margin -7.78
Operating Margin -522.47
Return On Equity 0.00
Return On Assets 0.00
Inventory Turnover (TTM) 0.00
Sales Growth (MRQ) 23.69

Ratios

as of 4:00 PM ET 09/20/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 2.22
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) 0.89
Quick Ratio (MRQ) 4.17
Current Ratio (MRQ) 4.22
Total Debt/Equity (MRQ) 0.04

Short Interest

as of 2:55 PM ET 09/21/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 09/20/2021
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Consensus Estimate $-0.35 $-0.35
# of Estimates 1 1
High Estimate $-0.35 $-0.35
Low Estimate $-0.35 $-0.35
Year Ago EPS $-0.28 $-0.28
Year Over Year Growth Estimate 23.11% 23.11%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $-1.34 $-1.19
# of Estimates 1 1
High Estimate $-1.34 $-1.19
Low Estimate $-1.34 $-1.19
Year Ago EPS $-4.83 $-1.34
Year Over Year Growth Estimate -72.26% -11.19%
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $-0.35 $-0.35 $-1.34 $-1.19
# of Estimates 1 1 1 1
High Estimate $-0.35 $-0.35 $-1.34 $-1.19
Low Estimate $-0.35 $-0.35 $-1.34 $-1.19
Year Ago EPS $-0.28 $-0.28 $-4.83 $-1.34
Year Over Year Growth Estimate 23.11% 23.11% -72.26% -11.19%

Insider Information Summary

as of 08/31/2021
% Insiders - 0.07%
% Remaining Total Shares - 99.93%
Current 1 Month
Net Insider Transaction 0.00 0.00
Shares Bought 0.00 0.00
Shares Sold 0.00 0.00

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Zoom Video Stock in High Resolution as Guggenheim Taps Videoconference Firm Buy

Zoom Video's $15 Billion Purchase of Five9 Faces DOJ Scrutiny on China Ties

Zoom Video has run into trouble with U.S. regulators before over its ties to China.

Taxes and Cryptocurrencies Lead

Stock Market Today With Jim Cramer: Rein in Some Crypto Investments

Jim Cramer discusses why it's time to sell some crypto investments and Tuesday's market.

Helbiz Lead

Helbiz Stocks Soars to the Heavens on Amazon Deal

Helbiz nearly triples after reaching an agreement under which Helbiz Live will be streamed on Amazon Prime Video channels.

Not So Easy Picking Winners and Losers Under Trump -- Stephen Guilfoyle

Stocks Sold for Tax-Loss Harvesting Can be Buys For Next Year

Real Money’s Jonathan Heller looks at the strategy for buying stocks poised to rebound after the first of the year.

Vail Resorts Posts Wider Loss but Analyst Sees Strong Growth Ahead

Vail Resorts Stock Upgrades to Overweight, Shares Firm

'Metrics we use to track intra-quarter pass sales appear robust,' writes KeyBanc analyst Brett Andress. He has a $355 price target.

market volatility VIAVAL TOURS : Shutterstock

Traders Had Plenty of Warning About This Volatility

Failed bounces are a part of any corrective action in the market, James "Rev Shark" Deporre says.

Disruptive Technology Like Uber Will Weigh on Medallion Financial

5 Top Stock Gainers for Tuesday: Uber, Helbiz, Warner Music

Uber Technologies, Helbiz, Warner Music Group, Upstart Holdings and QuantumScape are five top stock gainers for Tuesday.

Palo Alto Networks CEO Probably Just Revealed Why His Stock Is Up More Than 15% Inside a Month

Jim Cramer Talks Home Cybersecurity With Palo Alto Networks

The CEO of the cybersecurity company tells 'Mad Money's' Jim Cramer about what's driving its growth.

Cathie Wood Lead

Cathie Wood's Ark Snaps Up Coinbase, Robinhood

Ark's ETFs also buy streaming platform Roku, real estate services provider Zillow and Zoom Video, as prices fell Monday.

Bull Bear Market Economy

Buy the Dip in Stocks or Wait for More Downside?

We've finally seen some air come out of the stock market. But is the dip safe to buy or should investors wait? Here's the technicals.